Generate Biomedicines, Inc.
GENB
NASDAQ·Healthcare·Biotechnology·Mkt cap $2.1B
$16.28
▲ +3.10%
P/E
-15.36
Mkt Cap
$2.1B
52-Wk Range
$11.00–$22.67
52-Week Range
$11.00 - $22.67
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 28.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary machine learning platform for protein engineering
- Integrated computational and biohardware infrastructure
- Diverse protein modality expertise across multiple therapeutic areas
- First-mover advantage in generative biology space
Bear Case
1 risk
- Low volatility (beta -0.1).
Growth
Strong growth ahead
Advancement of GB-0895 through clinical trials for severe asthma market
Value
Deep value opportunity - significant discount to Asset Management peers
Momentum
Hot
+36.0% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying GENB right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 2, 2026
AUG 6, 2026
Reported EPS of -$0.52 vs -$0.51 consensus (-2.3% surprise). Revenue of $6.3M vs $5.3M expected (+19.1%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-2.3%
Revenue trend · last 2Q
—
—
Q1 26
Q2 26
$7.2M
$6.3M
Margins · last 2Q
Profit
-1065.2%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · Aug 28, 2026
vs Industry
How GENB stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related